Skip to main content
Premium Trial:

Request an Annual Quote

Astex Extends X-ray Crystallography Deal with AstraZeneca

NEW YORK, July 7 - Structure-based drug discovery firm Astex Technology said it has extended a research collaboration with AstraZeneca based on its high-throughput X-ray crystallography technology.


The collaboration, which began in May 2001, has been extended an additional three years. Astex will continue to apply its technology to obtain crystal structures of human cytochrome P450s alone and in complex with AstraZeneca's compounds.


Financial details of the agreement were not disclosed.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.